keyword
https://read.qxmd.com/read/38630180/tavac-comprehensive-review-of-currently-available-hemostatic-products-as-adjunct-to-surgical-hemostasis
#1
JOURNAL ARTICLE
Iswanto Sucandy, Sharona Ross, Jonathan DeLong, Michael Tran, Fred Qafiti, David Pechman, Tim Snow, Salvatore Docimo, Allyson Lim-Dy, Maria Christodoulou, David Renton
BACKGROUND: The use of hemostatic agents by general surgeons during abdominal operations is commonplace as an adjunctive measure to minimize risks of postoperative bleeding and its downstream complications. Proper selection of products can be hampered by marginal understanding of their pharmacokinetics and pharmacodynamics. While a variety of hemostatic agents are currently available on the market, the choice of those products is often confusing for surgeons. This paper aims to summarize and compare the available hemostatic products for each clinical indication and to ultimately better guide surgeons in the selection and proper use of hemostatic agents in daily clinical practice...
April 17, 2024: Surgical Endoscopy
https://read.qxmd.com/read/38628390/development-of-a-novel-endoscopic-hemostasis-assisted-navigation-ai-system-in-the-standardization-of-post-esd-coagulation
#2
JOURNAL ARTICLE
Haruka Fujinami, Shun Kuraishi, Akira Teramoto, Seitaro Shimada, Saeko Takahashi, Takayuki Ando, Ichiro Yasuda
Background and study aims While gastric endoscopic submucosal dissection (ESD) has become a treatment with fewer complications, delayed bleeding remains a challenge. Post-ESD coagulation (PEC) is performed to prevent delayed bleeding. Therefore, we developed an artificial intelligence (AI) to detect vessels that require PEC in real time. Materials and methods Training data were extracted from 153 gastric ESD videos with sufficient images taken with a second-look endoscopy (SLE) and annotated as follows: (1) vessels that showed bleeding during SLE without PEC; (2) vessels that did not bleed during SLE with PEC; and (3) vessels that did not bleed even without PEC...
April 2024: Endoscopy International Open
https://read.qxmd.com/read/38628188/can-daily-consumption-of-enriched-fatty-acids-diet-be-effective-in-improving-metabolic-syndrome-an-attractive-paradox-for-walnut-kernel
#3
REVIEW
Melika Samei, Nafiseh Dowlatkhahi, Motahareh Boozari, Hossein Hosseinzadeh
Imagine consuming a daily diet rich in fatty acids to help treat diseases such as hypertension and obesity. This concept presents an attractive paradox. In particular, consuming walnut kernels is beneficial for treating diseases associated with metabolic syndrome (MetS), including type 2 diabetes, cardiovascular disease, dyslipidemia, and obesity. Different parts of the Juglans regia tree (family Juglandaceae), including its leaves, green husks, bark, and septum, have shown promising effects on pathological conditions related to MetS...
April 2024: Food Science & Nutrition
https://read.qxmd.com/read/38627244/subcostal-bilateral-internal-thoracic-artery-harvesting-with-the-da-vinci-sp-system-an-experimental-feasibility-study
#4
JOURNAL ARTICLE
Hubert Stein, Volkmar Falk, Joseph Zacharias, Michael Ikeda, John Michael Smith, Georgia Crichton, Louis Ryckembusch, Jörg Kempfert
We evaluated the feasibility of harvesting bilateral internal thoracic arteries with the da Vinci SP through a single left sided subcostal incision. Complete bilateral mobilization with sufficiently long conduits for multivessel grafting was possible in two human cadavers and two live porcine. Creating the subcostal access and docking the SP system took between 14 to 21 min and total harvest time ranged from 65 to 125 minutes in all models. No major bleeding was observed in the live porcine and hemostasis managed with the available instrumentation...
April 16, 2024: Interdiscip Cardiovasc Thorac Surg
https://read.qxmd.com/read/38626900/practical-suggestions-for-an-optimal-management-of-vitamin-k-antagonists-italian-federation-of-centers-for-the-diagnosis-of-thrombotic-disorders-and-the-surveillance-of-the-antithrombotic-therapies-fcsa-position-paper
#5
JOURNAL ARTICLE
Silvia Galliazzo, Paolo Bucciarelli, Doris Barcellona, Antonio Ciampa, Elvira Grandone, Giuseppe Malcangi, Giuseppe Rescigno, Alessandro Squizzato, Vincenzo Toschi, Sophie Testa, Daniela Poli
In the era of direct oral anticoagulants, vitamin K antagonists retain a clinically relevant role in thrombotic disorders. In Italy, approximately 20% of the patients on anticoagulant therapies receives a VKA, in most cases warfarin. The optimal management of this drug is challenging and cannot disregard its intricate and unpredictable pharmacokinetic properties and patient's thrombotic and bleeding risk. Several clinical issues encountered during warfarin treatment are still unanswered and are tentatively addressed by physicians...
April 16, 2024: Thrombosis and Haemostasis
https://read.qxmd.com/read/38626899/the-role-of-clot-waveform-analysis-and-related-parameters-in-the-diagnosis-and-treatment-of-hemophilia-a
#6
JOURNAL ARTICLE
Guanghao Song, Yangbin Wang, Lilei Zhang, Mao Xia
BACKGROUND:  Hemophilia A (HA) is an inherited bleeding disorder caused by a deficiency or defect in factor VIII (FVIII). METHODS:  We investigated the role of clot waveform analysis (CWA) of activated partial thromboplastin time in the diagnosis and therapeutic monitoring of HA. The changes in CWA parameters the maximum clotting velocity (|Min1|), maximum clotting acceleration (|Min2|), and maximum clotting deceleration (|Max2|) were detected among mild, moderate, and severe HA groups...
April 16, 2024: Thrombosis and Haemostasis
https://read.qxmd.com/read/38626898/clinical-outcomes-of-patients-with-atrial-fibrillation-who-survived-from-bleeding-event-the-results-from-cool-af-thailand-registry
#7
JOURNAL ARTICLE
Arjbordin Winijkul, Pontawee Kaewkumdee, Ahthit Yindeengam, Gregory Y H Lip, Rungroj Krittayaphong
BACKGROUND:  Bleeding events are often reported among patients with atrial fibrillation (AF), irrespective of antithrombotic use. This study is to determine clinical outcomes of patients with AF who survived from bleeding event. METHODS:  We analyzed data from COOL-AF (Cohort of Antithrombotic Use and Optimal International Normalized Ratio Levels in Patients with Atrial Fibrillation) Thailand registry. Outcomes of patients who experienced any bleeding were compared with patients who had never bleed...
April 16, 2024: Thrombosis and Haemostasis
https://read.qxmd.com/read/38626592/is-there-a-role-for-the-laboratory-monitoring-in-the-management-of-specific-antidotes-of-direct-oral-anticoagulants
#8
REVIEW
Nicolas Gendron, Paul Billoir, Virginie Siguret, Véronique Le Cam-Duchez, Valérie Proulle, Laurent Macchi, Elodie Boissier, Christine Mouton, Emmanuel De Maistre, Isabelle Gouin-Thibault, Georges Jourdi
Given the growing number of patients receiving direct oral anticoagulant (DOAC), patients requiring rapid neutralization is also increasing in case of major bleedings or urgent surgery/procedures. Idarucizumab is commercialized as a specific antidote to dabigatran while andexanet alfa has gained the Food and Drug Administration and the European Medicines Agency approval as an oral anti-factor Xa inhibitors antidote. Other antidotes or hemostatic agents are still under preclinical or clinical development, the most advanced being ciraparantag...
April 10, 2024: Thrombosis Research
https://read.qxmd.com/read/38626584/corrigendum-to-a-self-gelling-powder-based-on-polyacrylic-acid-polyacrylamide-quaternate-chitosan-for-rapid-hemostasis-int-j-biol-macromol-232-2023-123449
#9
Zhouying Tan, Xi Li, Chaojie Yu, Mengmeng Yao, Zhongming Zhao, Bingyan Guo, Lei Liang, Yuping Wei, Fanglian Yao, Hong Zhang, Junjie Li
No abstract text is available yet for this article.
April 15, 2024: International Journal of Biological Macromolecules
https://read.qxmd.com/read/38626528/evaluating-the-learning-curve-of-endoscopic-surgery-for-spontaneous-intracerebral-hemorrhage-a-single-center-experience-in-a-county-hospital
#10
JOURNAL ARTICLE
Shuang Liu, Shengyang Su, Jinyong Long, Shikui Cao, Jirao Ren, Fuhua Li, Zihui Gao, Huaxing Gao, Deqiang Wang, Fan Hu, Xiaobiao Zhang
BACKGROUND: Endoscopic surgery has shown promise in treating Spontaneous Intracerebral Hemorrhage (sICH), but its adoption in county-level hospitals has been hindered by the high level of surgical expertise required. METHODS: In this retrospective study at a county hospital, we utilized a Cumulative Sum (CUSUM) control chart to visualize the learning curve for two neurosurgeons. We compared patient outcomes in the learning and proficient phases, and compared them with expected outcomes based on ICH score and ICH functional outcome score, respectively...
April 15, 2024: Journal of Clinical Neuroscience: Official Journal of the Neurosurgical Society of Australasia
https://read.qxmd.com/read/38626407/platelet-membrane-coated-r-sak-improves-thrombolytic-efficacy-by-targeting-thrombus
#11
JOURNAL ARTICLE
Rui Hua, Mingxi Li, Qingxia Lin, Mengying Dong, Xiaoxuan Gong, Zhenyu Lin, Yule Li, Chen Li, Tian Wu, Chunyue Tan, Wenhao Zhang, Qin Wang, Tianyu Wu, Xiaoyu Zhou, Fang Yang, Chunjian Li
Thrombolytic therapy is one of the most effective treatments for thrombus dissolution and recanalization of blocked vessels in thrombotic diseases. However, the application of the thrombolytic strategy has been limited due to unsatisfactory thrombolytic efficacy, relatively higher bleeding complications, and consequently restricted indications. Recombinant staphylokinase (r-SAK) is a third-generation thrombolytic agent produced by genetic engineering technology, which exhibits a better thrombolytic efficacy than urokinase and recombinant streptokinase...
April 16, 2024: ACS Applied Materials & Interfaces
https://read.qxmd.com/read/38625834/clinical-study-reveals-the-efficacy-of-sirolimus-in-treating-primary-immune-thrombocytopenia-findings-from-a-single-center-study
#12
JOURNAL ARTICLE
Yaqing Feng, Haitao Meng, Caiqin Mu, Yanfang Zhang, Xi Liu, Yaqun Shi, Hongjin Wang
Immune thrombocytopenia (ITP) is an autoimmune disease that arises because of self-destruction of circulating platelets. The mechanism remains complicated and lacks a standard clinical treatment. Current first-line and second-line medications for ITP have shown limited effectiveness, necessitating the exploration of new therapeutic options. Sirolimus is a mammalian target of rapamycin (mTOR) inhibitor that has been demonstrated to inhibit lymphocyte activity, indicating potential for SRL in the treatment of ITP...
April 16, 2024: Blood Coagulation & Fibrinolysis: An International Journal in Haemostasis and Thrombosis
https://read.qxmd.com/read/38625831/plasma-tissue-factor-pathway-inhibitor-levels-in-coronavirus-disease-2019-patients-a-systematic-review-and-meta-analysis
#13
JOURNAL ARTICLE
Saeed Hassani, Mohammad Sayyadi, Amir Almasi-Hashiani
UNLABELLED: Studies have suggested a relationship between tissue factor pathway inhibitor (TFPI) and coronavirus disease 2019 (COVID-19) severity. However, there is inconsistency in the findings of the studies. To enhance comprehension of this relationship, a meta-analysis was conducted. PubMed, Web of Science, and Scopus databases were searched to identify eligible studies. The mean difference was employed as effect measures and the standardized mean difference (SMD) and the 95% confidence interval (CI) were utilized as a summary statistic...
April 5, 2024: Blood Coagulation & Fibrinolysis: An International Journal in Haemostasis and Thrombosis
https://read.qxmd.com/read/38625829/efficacy-of-emicizumab-therapy-in-two-adult-patients-with-type-3-von-willebrand-disease
#14
JOURNAL ARTICLE
Frederick Ian LeMaistre, Elaine Chiang, Michael B Streiff, Jennifer C Yui
Type 3 von Willebrand disease (T3VWD) is a rare inherited bleeding disorder caused by the absence of von Willebrand factor (VWF). The traditional treatment for T3VWD has been VWF concentrates, but their effectiveness may be limited due to the development of alloantibodies. Emicizumab, a bispecific mAb, has shown promise in treating hemophilia A and is being studied as prophylaxis for T3VWD. In this case series, two patients with T3VWD received emicizumab prophylaxis and experienced a significant reduction in bleeding episodes and improved quality of life with fewer healthcare encounters...
March 27, 2024: Blood Coagulation & Fibrinolysis: An International Journal in Haemostasis and Thrombosis
https://read.qxmd.com/read/38623878/a-rare-complication-of-pediatric-liver-transplantation-post-transplant-diaphragmatic-hernia
#15
JOURNAL ARTICLE
Ulgen Celtik, Zafer Dokumcu, Coskun Ozcan, Orkan Ergün
AIM: Acquired post-transplant diaphragmatic hernia (PTDH) is a rare complication of liver transplantation (LT) in children. We aimed to present our experience in PTDH, and a possible causative background is discussed. METHODS: Medical records of patients who had undergone diaphragmatic repair following LT between 2015 and 2023 were reviewed. Demographic information, details of primary diseases necessitating LT, transplantation techniques, and clinical findings associated with PTDH were evaluated...
May 2024: Pediatric Transplantation
https://read.qxmd.com/read/38623474/testing-for-the-lupus-anticoagulant-the-good-the-bad-and-the-ugly
#16
JOURNAL ARTICLE
Emmanuel J Favaloro, Leonardo Pasalic, Rita Selby
Lupus anticoagulant (LA) represents 1 of the laboratory criteria for classification of patients as having definite antiphospholipid syndrome (APS). The other 2 laboratory criteria are anticardiolipin antibodies and anti-beta2-glycoprotein I antibodies. At least 1 of these antiphospholipid antibody (aPL) tests need to be positive, with evidence of persistence, together with evidence of at least 1 clinical criterion for APS, before a patient can be classified as having definite APS. LA and other aPL assays are also important for diagnosis or exclusion of APS, as well as for risk stratification, with triple-positive patients carrying the greatest risk...
March 2024: Research and Practice in Thrombosis and Haemostasis
https://read.qxmd.com/read/38623473/tranexamic-acid-for-management-of-heavy-vaginal-bleeding-barriers-to-access-and-myths-surrounding-its-use
#17
JOURNAL ARTICLE
Heather VanderMeulen, Grace H Tang, Michelle Sholzberg
Tranexamic acid is safe and effective for the treatment of heavy vaginal bleeding during menstruation and childbirth. It improves the quality of life, facilitates participation in school and work, and reduces the risk of death from postpartum hemorrhage. Despite its well-established benefits, individual- and structural-level barriers preclude its widespread utilization, hindering effective patient care and perpetuating health inequities in women's health. We first describe the evidence for the use of tranexamic acid in treating heavy menstrual bleeding and postpartum hemorrhage...
March 2024: Research and Practice in Thrombosis and Haemostasis
https://read.qxmd.com/read/38623472/ticagrelor-vs-clopidogrel-when-coadministered-with-bivalirudin-in-patients-with-acute-coronary-syndrome-undergoing-percutaneous-coronary-intervention
#18
JOURNAL ARTICLE
Yang Li, Yi Li, Miaohan Qiu, Yu Xue, Kai Xu, Yaling Han
BACKGROUND: The optimal perioperative antithrombotic strategy for patients with acute coronary syndrome (ACS) during percutaneous coronary intervention (PCI) remains controversial. OBJECTIVES: To determine the safety and effectiveness of bivalirudin plus ticagrelor vs bivalirudin plus clopidogrel in patients with ACS undergoing PCI in the real world. METHODS: Between March 2016 and March 2019, 7234 patients with ACS who had undergone PCI, received bivalirudin periprocedurally, and were prescribed ticagrelor or clopidogrel were enrolled in a single-center, all-comer, modern, retrospective cohort study...
March 2024: Research and Practice in Thrombosis and Haemostasis
https://read.qxmd.com/read/38621742/post-translational-oxidative-modifications-of-hemostasis-proteins-structure-function-and-regulation
#19
REVIEW
Mark A Rosenfeld, Lyubov V Yurina, Elizaveta S Gavrilina, Alexandra D Vasilyeva
Reactive oxygen species (ROS) are constantly generated in a living organism. An imbalance between the amount of generated reactive species in the body and their destruction leads to the development of oxidative stress. Proteins are extremely vulnerable targets for ROS molecules, which can cause oxidative modifications of amino acid residues, thus altering structure and function of intra- and extracellular proteins. The current review considers the effect of oxidation on the structural rearrangements and functional activity of hemostasis proteins: coagulation system proteins such as fibrinogen, prothrombin/thrombin, factor VII/VIIa; anticoagulant proteins - thrombomodulin and protein C; proteins of the fibrinolytic system such as plasminogen, tissue plasminogen activator and plasminogen activator inhibitor-1...
January 2024: Biochemistry. Biokhimii︠a︡
https://read.qxmd.com/read/38621318/association-between-perioperative-red-blood-cell-transfusions-and-postoperative-venous-thromboembolism-a-systematic-review-and-meta-analysis
#20
JOURNAL ARTICLE
Mengyan Mo, Zerong Lian, Yongyan Xiang, Xiaogang Du, Hua Liu, Jie Sun, Rui Wang
BACKGROUND: Whether perioperative red blood cell transfusions increases the risk of postoperative venous thromboembolism is controversial and uncertain.We aims to explore the relationship between perioperative red blood cell transfusions and the risk of postoperative venous thromboembolism by conducting a meta-analysis. OBJECTIVE: To conduct a meta-analysis to systematically evaluate the relationship between perioperative red blood cell transfusions and the risk of postoperative venous thromboembolism...
April 3, 2024: Thrombosis Research
keyword
keyword
5665
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.